Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-052313
Filing Date
2025-04-09
Accepted
2025-04-09 08:27:25
Documents
1
Period of Report
2025-04-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3941
  Complete submission text file 0000950170-25-052313.txt   5400
Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451
Business Address
Hoerter Steven L. (Reporting) CIK: 0001533451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42272 | Film No.: 25823891

Mailing Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 300 CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Issuer) CIK: 0001776111 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)